Grundium has joined forces with Visiopharm, a global leader in AI-driven precision pathology software, to expand the availability of accessible digital pathology solutions for clinics and laboratories worldwide. Through this partnership, Visiopharm will offer Grundium’s Ocus® scanners alongside its Qualitopix™ solution, enabling labs to automatically upload images for processing. Qualitopix empowers labs to enhance their staining […]
Grundium has joined forces with Visiopharm, a global leader in AI-driven precision pathology software, to expand the availability of accessible digital pathology solutions for clinics and laboratories worldwide. Through this partnership, Visiopharm will offer Grundium’s Ocus® scanners alongside its Qualitopix™ solution, enabling labs to automatically upload images for processing. Qualitopix empowers labs to enhance their staining quality and standardization by monitoring staining consistency.
Grundium’s Ocus scanners are well known for their exceptional image quality, user-friendly design, and compact footprint. Seamlessly integrating with computational pathology applications, these scanners provide an affordable option for accelerating the adoption of pathology AI applications. With a web-based user interface and cloud connectivity, the Ocus scanner portfolio stands out as a practical imaging instrument for digital pathology.
Qualitopix combines powerful AI technology with control materials, enabling labs to continuously monitor and document staining consistency over time. By utilizing standardized and validated control materials, labs can obtain reliable and actionable insights that help identify staining performance variations. One of the key advantages of Qualitopix is its simplicity, speed, and cost-effectiveness. As a web-based solution, labs can seamlessly incorporate it into their existing workflows, unlocking the benefits of digital pathology without significant implementation efforts. The integration of Grundium’s Ocus scanners enhances the automation of Visiopharm’s Qualitopix™ solution by facilitating the automatic upload of images.
Martin Kristensson, Senior Vice President of Clinical Commercial Strategy at Visiopharm, says: At Visiopharm, we are constantly seeking ways to help pathology labs standardize their work. Our partnership with Grundium and the integration of the Ocus scanner with our Qualitopix solution offers a powerful combination of high-quality imaging and staining monitoring, providing pathology labs with the necessary tools to gain insights into their daily performance. We are excited to introduce these innovative digital pathology solutions to more clinics and labs worldwide, aiming to make a positive impact on standardization.
According to Grundium’s Sales Director, Davide D’Incau, breakthroughs in AI and computational pathology will significantly impact the field of pathology. Grundium is dedicated to making these innovations widely accessible to clinicians and labs by providing the most practical imaging instruments for digital pathology in the market. We are thrilled to include the Ocus® scanners as part of Visiopharm’s solutions, starting with Qualitopix.
A global leader in advanced imaging technology, Grundium makes digital pathology and the best professional diagnosis available for all life – whether human, animal, plant, or other. This is achieved by doing something that nobody else can: applying state-of-the-art mobile technology in digital pathology. Established in 2015 by ex-Nokia engineers, the Tampere-based company is democratizing digital pathology with the Ocus® microscope scanners. The cutting-edge imaging solutions are based on over 20 years of experience in optics, sensors and beautiful high-precision devices. Grundium serves various industries and businesses, enhancing quality and processes, protecting human life, and safeguarding a clean environment.
Visiopharm® is a leading provider of AI-driven precision pathology software for research and diagnostics. In research, it is a technology leader providing tools that help scientists, pathologists, and image analysis experts produce accurate data for all types of tissue-based research. In diagnostics, it is a leader in clinical applications, with no less than eight diagnostic algorithms cleared under IVDR for EU customers. These applications provide diagnostic decision support and can be easily activated and integrated into existing lab workflows.
Founded in 2002, Visiopharm is privately owned and operates internationally with over 750 customer accounts in more than 40 countries. The company’s headquarters are located in Denmark’s Medicon Valley, with offices in Sweden, the UK, Germany, the Netherlands, and the United States, and local representation in France and China.
Grundium:
Davide D’Incau
Sales Director
davide.dincau@grundium.com
Visiopharm:
Johanne Louise Brændgaard
Chief Marketing Officer
jlb@visiopharm.com
